BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25440959)

  • 1. Dysplastic nevi, cutaneous melanoma, and other skin neoplasms in patients with myotonic dystrophy type 1: a cross-sectional study.
    Zampetti A; Silvestri G; Manco S; Khamis K; Masciullo M; Bianchi ML; Damiani A; Santoro M; Linder D; Bewley A; Feliciani C
    J Am Acad Dermatol; 2015 Jan; 72(1):85-91. PubMed ID: 25440959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous features of myotonic dystrophy types 1 and 2: Implication of premature aging and vitamin D homeostasis.
    Campione E; Botta A; Di Prete M; Rastelli E; Gibellini M; Petrucci A; Bernardini S; Novelli G; Bianchi L; Orlandi A; Massa R; Terracciano C
    Neuromuscul Disord; 2017 Feb; 27(2):163-169. PubMed ID: 28065683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysplastic nevi are a risk factor for uveal melanoma.
    Hammer H; Oláh J; Tóth-Molnár E
    Eur J Ophthalmol; 1996; 6(4):472-4. PubMed ID: 8997595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The number and distribution of nevus cell nevi in patients with malignant melanoma].
    Welkovich B; Landthaler M; Schmoeckel C; Braun-Falco O
    Hautarzt; 1989 Oct; 40(10):630-5. PubMed ID: 2613517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular melanoma: epidemiology, clinical presentation and relationship with dysplastic nevi.
    Richtig E; Langmann G; Müllner K; Smolle J
    Ophthalmologica; 2004; 218(2):111-4. PubMed ID: 15004500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma.
    Tucker MA; Halpern A; Holly EA; Hartge P; Elder DE; Sagebiel RW; Guerry D; Clark WH
    JAMA; 1997 May; 277(18):1439-44. PubMed ID: 9145715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic.
    Risser J; Pressley Z; Veledar E; Washington C; Chen SC
    J Am Acad Dermatol; 2007 Sep; 57(3):428-34. PubMed ID: 17624623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects.
    Nordlund JJ; Kirkwood J; Forget BM; Scheibner A; Albert DM; Lerner E; Milton GW
    Cancer Res; 1985 Apr; 45(4):1855-61. PubMed ID: 3978645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with the prevalence of atypical nevus in a Mediterranean pigmented skin lesion clinic.
    Lasithiotakis KG; Kokolakis A; Giannikaki E; Krasagakis K; Tosca A
    Melanoma Res; 2011 Oct; 21(5):469-73. PubMed ID: 21760555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma risk in individuals with clinically atypical nevi.
    Kang S; Barnhill RL; Mihm MC; Fitzpatrick TB; Sober AJ
    Arch Dermatol; 1994 Aug; 130(8):999-1001. PubMed ID: 8053717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biopsy diagnoses of clinically atypical pigmented lesions of the head and neck in adults.
    Udovenko O; Griffin JR; Elston DM
    Am J Dermatopathol; 2014 Oct; 36(10):829-31. PubMed ID: 25247672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.
    Banky JP; Kelly JW; English DR; Yeatman JM; Dowling JP
    Arch Dermatol; 2005 Aug; 141(8):998-1006. PubMed ID: 16103329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Do Finnish melanoma patients have dysplastic nevi?].
    Lapatto O; Kariniemi AL; Asko-Seljavaara S
    Duodecim; 1992; 108(11):1054-8. PubMed ID: 1366023
    [No Abstract]   [Full Text] [Related]  

  • 14. Dysplastic nevi and other risk markers for melanoma.
    Seykora J; Elder D
    Semin Oncol; 1996 Dec; 23(6):682-7. PubMed ID: 8970587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysplastic nevi in relation to superficial spreading melanoma.
    Titus-Ernstoff L; Barnhill RL; Duray PH; Ernstoff MS; Kirkwood JM
    Cancer Epidemiol Biomarkers Prev; 1993; 2(2):99-101. PubMed ID: 8467253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common and dysplastic naevi as risk factors for cutaneous malignant melanoma in a Swedish population.
    Augustsson A; Stierner U; Rosdahl I; Suurküla M
    Acta Derm Venereol; 1991; 71(6):518-24. PubMed ID: 1685835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular findings in patients with dysplastic nevus syndrome. An update.
    Rodriguez-Sains RS
    Dermatol Clin; 1991 Oct; 9(4):723-8. PubMed ID: 1934647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between basal, squamous cell carcinomas, dysplastic nevi and myotonic muscular dystrophy indicates an important role of RNA-binding proteins in development of human skin cancer.
    Zemtsov A
    Arch Dermatol Res; 2010 Apr; 302(3):169-70. PubMed ID: 19902230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS; Shakhtour B; Shyr Y
    J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study.
    Halpern AC; Guerry D; Elder DE; Clark WH; Synnestvedt M; Norman S; Ayerle R
    Arch Dermatol; 1991 Jul; 127(7):995-9. PubMed ID: 2064418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.